Publications

Download publications: 
Expand all
2018
  • Hilton, H., Clarke, C., Graham, J. (2018). Estrogen and progesterone signalling in the normal breast and its implications for cancer development. Molecular And Cellular Endocrinology. 466 , 2-14. [More Information]
  • Hilton, H., Clarke, C., Graham, J. (2018). Estrogen and progesterone signalling in the normal breast and its implications for cancer development. Molecular And Cellular Endocrinology. 466 , 2-14. [More Information]

2017
  • Hilton, H., Graham, J., Clarke, C. (2017). Cancer Therapeutic Targets. Cancer Therapeutic Targets. 1 , 1029-1038. [More Information]
  • Hilton, H., Graham, J., Clarke, C. (2017). Cancer Therapeutic Targets. Cancer Therapeutic Targets. 1 , 1029-1038. [More Information]
  • Hilton, H., Graham, J., Clarke, C. (2017). PR. Cancer Therapeutic Targets. 1 , 1029-1038. [More Information]

    Show 1 more
  • Hilton, H., Graham, J., Clarke, C. (2017). PR. Cancer Therapeutic Targets. 1 , 1029-1038. [More Information]

2015
  • Hilton, H., Clarke, C. (2015). Impact of Progesterone on Stem/Progenitor Cells in the Human Breast. Journal of Mammary Gland Biology and Neoplasia. 20 (1-2) , 27-37. [More Information]
  • Hilton, H., Graham, J., Clarke, C. (2015). Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?. Molecular Endocrinology. 29 (9) , 1230-1242. [More Information]
  • Clarke, C., Dontu, G., Hilton, H., Meier-Abt, F., Sartorius, C. (2015). Preface. Journal of Mammary Gland Biology and Neoplasia. 20 (1-2) , 5-7. [More Information]

    Show 3 more
  • Mote, P., Gompell, A., Howe, C., Hilton, H., Sestak, I., Cuzick, J., Dowsett, M., Hugol, D., Forgez, P., Byth Wilson, K., Graham, J., Clarke, C. (2015). Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Research and Treatment. 151 (2) , 309-318. [More Information]
  • Mote, P., Gompell, A., Howe, C., Hilton, H., Sestak, I., Cuzick, J., Dowsett, M., Hugol, D., Forgez, P., Byth Wilson, K., Graham, J., Clarke, C. (2015). Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Research and Treatment. 151 (2) , 309-318. [More Information]
  • Mote, P., Gompell, A., Howe, C., Hilton, H., Sestak, I., Cuzick, J., Dowsett, M., Hugol, D., Forgez, P., Byth Wilson, K., Graham, J., Clarke, C. (2015). Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.. Breast Cancer Research and Treatment. 151 (2) , 309-318. [More Information]

2014
  • Hilton, H., Doan, T., Graham, J., Oakes, S., Silvestri, A., Santucci, N., Kantimm, S., Huschtscha, L., Ormandy, C., Funder, J., Kuczek, E., Clarke, C., et al (2014). Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. Oncotarget. 5 (18) , 8651-8664.
  • Hilton, H., Santucci, N., Silvestri, A., Kantimm, S., Huschtscha, L., Graham, J., Clarke, C. (2014). Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Research and Treatment. 143 (3) , 423-433.
  • Hilton, H., Graham, J. (2014). The molecular landscape of the normal human breast- defining normal. Breast Cancer Research. 16 (3) , 1-3. [More Information]

2013
  • Hilton, H., Kantimm, S., Graham, J., Clarke, C. (2013). Changed lineage composition is an early event in breast carcinogenesis. Histology and histopathology. 28 (9) , 1197-1204.

2012
  • Hilton, H., Graham, J., Clarke, C. (2012). Estrogen and Progestin Stimulation of Breast Proliferation. Translational Endocrinology & Metabolism: Breast Cancer Update. , 1-28.
  • Hilton, H., Graham, J., Kantimm, S., Santucci, N., Cloosterman, D., Huschtscha, L., Mote, P., Clarke, C. (2012). Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Molecular And Cellular Endocrinology. 361 (1-2) , 191-201. [More Information]

2010
  • Hilton, H., Kalyuga, M., Cowley, M., Alles, M., Lee, H., Caldon, C., Blazek, K., Kaplan, W., Musgrove, E., Daly, R., Graham, J., Clarke, C., et al (2010). The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5. Molecular Endocrinology. 24 (7) , 1380-1392. [More Information]

2008
  • Hilton, H., Stanford, P., Harris, J., Oakes, S., Kaplan, W., Daly, R., Ormandy, C. (2008). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids. 1783 (3) , 383-393. [More Information]
  • Oakes, S., Naylor, M., Asselin-Labat, M., Blazek, K., Gardiner-Garden, M., Hilton, H., Kazlauskas, M., Pritchard, M., Chodosh, L., Pfeffer, P., et al (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes and Development. 22 (5) , 581-586. [More Information]

2006
  • Oakes, S., Hilton, H., Ormandy, C. (2006). Key stages in mammary gland development: The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Research. 8 (2) , 207. [More Information]
  • Harris, J., Stanford, P., Sutherland, K., Oakes, S., Naylor, M., Robertson, F., Blazek, K., Kazlauskas, M., Hilton, H., Wittlin, S., et al (2006). Socs2 and elf5 mediate prolactin-induced mammary gland development. Molecular Endocrinology. 20 (5) , 1177-1187. [More Information]